accountAbbott Laboratories confirmed Wednesday morning that it stopped the study of an early-stage compound for Alzheimer's disease. The drug, which was in early human clinical trials, was not working. The...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott halts study on early-stage Alzheimer's drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account